We are excited and grateful to announce being awarded "Most Promising Company" following the pitch competition at the 2022 Texas Life Science Forum! #lifescience #precisionmedicine #oncology #biotech

EMPIRI has been selected to present at the Texas Life Science Forum on February 24, 2022, at the Jones Graduate School of Business, McNair Hall, Rice University, Houston, Texas. Company Showcase and Investor Office Hours will be held the day before the Forum. #lifescience #business #pitchcompetition #biotechnology #startup #medtechinnovator #meddevice #cancertreatment #cancercare #cancerdiagnostics #cancerpatients

Excited and grateful that we received $500K from an angel investor, enabling us to move forward with our CLIA LDT certification and prototype testing for CAL, a first-in-class precision cancer diagnostic instrument.

EMPIRI's co-founder Dr. Kyuson Yun will be presenting at the AACR, mini-symposium session "Ex Vivo Models for Understanding Genetic Variation, Metastasis, and Treatment Sensitivity" on our platform technology, "E-slice: A novel 3D culture platform for precision medicine". #medicine #technology #culture #precisionmedicine #precisiononcology #cancerdiagnostics #aacr #drugdevelopment #drugdiscovery #pharmaceutical